file photo

file photo

Clinical trial to begin for new Alzheimer’s disease treatment

Activation of signaling pathway is expected to regenerate neural cells.

A clinical trial of a new potential Alzheimer’s disease treatment at Northwest Clinical Research Center in Bellevue raises hopes of a therapeutic treatment for a disease that was the third-largest cause of death in the state during 2019.

According to the Alzheimer’s Association, there are over 120,000 Washingtonians living with Alzheimer’s disease as of last year.

A principal investigator of the clinical study, Dr. Arif Khan, said while it is not totally understood what causes Alzheimer’s, it happens when neural cells in the brain degenerate, entangle and receive protein deposits that affect their “connectivity,” to one another.

This causes a loss in cognitive function, irritability, mood swings, inability to sleep, paranoia and most notably, memory loss.

Khan said neuronal degeneration has been associated with aging since the 1970’s and can become fatal quickly as the disease progresses to more severe stages.

Khan said previously tested treatments have been generally ineffective. He said 50 years ago, researchers tried a treatment that made dopamine more available in the brain as a way to mitigate Alzheimer’s disease. He said this treatment was more-so a “band-aid,” solution.

He said 20 years ago researchers tried using monoclonal antibodies to absorb the protein deposits in the brain that obstructed the connectivity of neural cells.

The trial, conducted by Khan as well as other physicians throughout the U.S. will test a new treatment that he said activates a naturally-occurring pathway, called HGF/MET, to help the broken down neural cells regenerate and in-turn improve cognitive function.

Khan said the the small molecule that activates this pathway, known as ATH-1017, is expected to make neural cells more “young and active,” at least that is the theory behind the clinical trial.

The treatment will be administered with daily injections into patients. Khan compared the treatment to a small needle shot.

He also emphasized that the trial will include patients with mild to moderate Alzheimer’s disease. If the data from this study are positive, ATH-1017 could be studied in both more severe and earlier-stage Alzheimer’s patients.

Spokesperson for Athira Pharma, Maggie Beller, said the trial will include up to 300 participants, with two-thirds of them receiving the daily treatment and the other third receiving a placebo over six months.

For more information, visit https://www.athiraclinicaltrials.com/ or call 1-800-668-4717.


In consideration of how we voice our opinions in the modern world, we’ve closed comments on our websites. We value the opinions of our readers and we encourage you to keep the conversation going.

Please feel free to share your story tips by emailing editor@bellevuereporter.com.

To share your opinion for publication, submit a letter through our website https://www.bellevuereporter.com/submit-letter/. Include your name, address and daytime phone number. (We’ll only publish your name and hometown.) We reserve the right to edit letters, but if you keep yours to 300 words or less, we won’t ask you to shorten it.

More in News

Patrick Kim. Courtesy of the Department of Licensing.
Bellevue man defrauds clients from Korean community, joins insurance fraud most wanted

Patrick Kim failed to appear at the King County Superior Court for numerous felony charges.

Ribbon cutting ceremony for the first Pride flag crosswalk at Bellevue College on May 17. Courtesy of Bellevue College.
Bellevue College hosts ribbon cutting ceremony for first rainbow crosswalk

Two more rainbow crosswalks are in the works, with the second one being the Progress Pride flag.

Bellevue Downtown Association logo
Downtown Bellevue Association to host Police Chief Wendell Shirley for Q&A event

The event will take place on Tuesday, May 24, from 7:30 to 9 am at the Bellevue Club.

File photo.
King County Council approves creation of Cannabis Safety Taskforce amid rash of dispensary robberies

The multi-agency task force will cooperate to find ways to improve safety in the cash-only industry.

Screenshot from ORCA website
New ORCA system launches for regional transit across the Puget Sound

Overhaul includes new website, mobile application and digital business account manager.

Judged by XII: A King County Local Dive podcast. The hands shown here belong to Auburn Police Officer Jeffrey Nelson, who has been charged with homicide in the 2019 death of Jesse Sarey.
JUDGED BY XII (Episode 4): Foster mom wants accountability in Auburn cop’s upcoming murder trial

Special podcast series explores Auburn Police Officer Jeffrey Nelson’s role in the death of Jesse Sarey.

The Newport Team launches their rocket. Courtesy of AIA.
Newport High School team crowned National Champions at American Rocketry Challenge

The team will represent the United States at the International Rocketry Challenge this July.

Screenshot from Bellevue School Foundation website
Bellevue Schools Foundation to study affordable housing in the community

Research made possible with $250,000 grant from the Amazon Housing Equity Fund

FILE PHOTO: King County Sheriff’s Office deputies.
Dozens of King County Sheriff’s Office employees left jobs instead of getting vaccinated

This added on to the existing number of vacancies in the department.

Most Read